NYSE:CRMD

Cormedix Stock Insider Trading

etoro logo Buy CRMD
*Your capital is at risk
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026

CorMedix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.79. In total, the insiders bought 2.07M and sold 758.39K CRMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-64.79
Buy 2.07M shares
Sell 758.39K shares
66% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jan 23, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -64.79.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 24, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Dillione Janet
Director
Director 4 876
Value: $21.6K
Nov 24, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Dillione Janet
Director
Director 5 677
Value: $20.2K
Nov 24, 2025
Sell
Common Stock
S-Sale
Dillione Janet
Director
Director 26 343
Value: $261.6K
Nov 24, 2025
Buy
Common Stock
M-Exempt
Dillione Janet
Director
Director 8 000
Value: $22.8K
Nov 24, 2025
Buy
Common Stock
M-Exempt
Dillione Janet
Director
Director 7 790
Value: $31.4K
Nov 24, 2025
Buy
Common Stock
M-Exempt
Dillione Janet
Director
Director 4 876
Value: $21.6K
Nov 24, 2025
Buy
Common Stock
M-Exempt
Dillione Janet
Director
Director 5 677
Value: $20.2K
Nov 14, 2025
Sell
Common Stock
S-Sale
Dillione Janet
Director
Director 30 000
Value: $342.6K
Oct 23, 2025
Buy
Common Stock
P-Purchase
Kaplan Myron
Director
Director 25 000
Value: $275.5K
Sep 16, 2025
Buy
Common Stock
M-Exempt
Duncan Gregory Scott
Director
Director 13 333
Value: $110.9K
Sep 16, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Duncan Gregory Scott
Director
Director 13 333
Value: $110.9K
Sep 16, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Duncan Gregory Scott
Director
Director 13 333
Value: $110.9K
Sep 16, 2025
Buy
Common Stock
M-Exempt
Duncan Gregory Scott
Director
Director 13 333
Value: $110.9K
Sep 12, 2025
Buy
Common Stock
M-Exempt
Dunton Alan W
Director
Director 10 000
Value: $35.5K
Sep 12, 2025
Sell
Common Stock
S-Sale
Dunton Alan W
Director
Director 10 000
Value: $131.3K
Sep 12, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Dunton Alan W
Director
Director 10 000
Value: $35.5K
Sep 12, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Dunton Alan W
Director
Director 10 000
Value: $35.5K
Sep 12, 2025
Sell
Common Stock
S-Sale
Dunton Alan W
Director
Director 10 000
Value: $131.3K
Sep 12, 2025
Buy
Common Stock
M-Exempt
Dunton Alan W
Director
Director 10 000
Value: $35.5K
Sep 12, 2025
Buy
Common Stock
M-Exempt
Todisco Joseph
Chief Executive Officer
CEO / President 50 000
Value: $173.5K
Sep 12, 2025
Sell
Common Stock
S-Sale
Todisco Joseph
Chief Executive Officer
CEO / President 50 000
Value: $650.0K
Sep 12, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Todisco Joseph
Chief Executive Officer
CEO / President 50 000
Value: $173.5K
Sep 12, 2025
Buy
Stock Option (Right to Buy Common Stock)
M-Exempt
Todisco Joseph
Chief Executive Officer
CEO / President 50 000
Value: $173.5K
Sep 12, 2025
Sell
Common Stock
S-Sale
Todisco Joseph
Chief Executive Officer
CEO / President 50 000
Value: $650.0K
Sep 12, 2025
Buy
Common Stock
M-Exempt
Todisco Joseph
Chief Executive Officer
CEO / President 50 000
Value: $173.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CORMEDIX INC
CorMedix
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical setting...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE